Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Nontuberculous Mycobacterium Treatment Market, by Region, 2019-2027 (USD Billion)
1.2.2. Nontuberculous Mycobacterium Treatment Market, by Drug Type, 2019-2027 (USD Billion)
1.2.3. Nontuberculous Mycobacterium Treatment Market, by End Use Industries, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Nontuberculous Mycobacterium Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Nontuberculous Mycobacterium Treatment Market Dynamics
3.1. Nontuberculous Mycobacterium Treatment Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Growing number of chronic diseases.
3.1.1.2. Rising Aging population.
3.1.2. Market Challenges
3.1.2.1. High Treatment Cost.
3.1.3. Market Opportunities
3.1.3.1. Rising prevalence of lung disease.
3.1.3.2. Surging health care industry.
Chapter 4. Global Nontuberculous Mycobacterium Treatment Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Nontuberculous Mycobacterium Treatment Market, by Drug Type
6.1. Market Snapshot
6.2. Global Nontuberculous Mycobacterium Treatment Market by Drug Type, Performance - Potential Analysis
6.3. Global Nontuberculous Mycobacterium Treatment Market Estimates & Forecasts by Drug Type 2018-2027 (USD Billion)
6.4. Nontuberculous Mycobacterium Treatment Market, Sub Segment Analysis
6.4.1. Clarithromycin
6.4.2. Azithromycin
6.4.3. Rifampin
6.4.4. Rifabutin
6.4.5. Ethambutol
6.4.6. Streptomycin
6.4.7. Amikacin.
Chapter 7. Global Nontuberculous Mycobacterium Treatment Market, by End Use Industries
7.1. Market Snapshot
7.2. Global Nontuberculous Mycobacterium Treatment Market by End Use Industries, Performance - Potential Analysis
7.3. Global Nontuberculous Mycobacterium Treatment Market Estimates & Forecasts by End Use Industries 2018-2027 (USD Billion)
7.4. Nontuberculous Mycobacterium Treatment Market, Sub Segment Analysis
7.4.1. Hospitals Pharmacies
7.4.2. Private clinics
7.4.3. Drug stores and retail pharmacy
7.4.4. E-commerce
Chapter 8. Global Nontuberculous Mycobacterium Treatment Market, Regional Analysis
8.1. Nontuberculous Mycobacterium Treatment Market, Regional Market Snapshot
8.2. North America Nontuberculous Mycobacterium Treatment Market
8.2.1. U.S. Nontuberculous Mycobacterium Treatment Market
8.2.1.1. Drug Type breakdown estimates & forecasts, 2018-2027
8.2.1.2. End Use Industries breakdown estimates & forecasts, 2018-2027
8.2.2. Canada Nontuberculous Mycobacterium Treatment Market
8.3. Europe Nontuberculous Mycobacterium Treatment Market Snapshot
8.3.1. U.K. Nontuberculous Mycobacterium Treatment Market
8.3.2. Germany Nontuberculous Mycobacterium Treatment Market
8.3.3. France Nontuberculous Mycobacterium Treatment Market
8.3.4. Spain Nontuberculous Mycobacterium Treatment Market
8.3.5. Italy Nontuberculous Mycobacterium Treatment Market
8.3.6. Rest of Europe Nontuberculous Mycobacterium Treatment Market
8.4. Asia-Pacific Nontuberculous Mycobacterium Treatment Market Snapshot
8.4.1. China Nontuberculous Mycobacterium Treatment Market
8.4.2. India Nontuberculous Mycobacterium Treatment Market
8.4.3. Japan Nontuberculous Mycobacterium Treatment Market
8.4.4. Australia Nontuberculous Mycobacterium Treatment Market
8.4.5. South Korea Nontuberculous Mycobacterium Treatment Market
8.4.6. Rest of Asia Pacific Nontuberculous Mycobacterium Treatment Market
8.5. Latin America Nontuberculous Mycobacterium Treatment Market Snapshot
8.5.1. Brazil Nontuberculous Mycobacterium Treatment Market
8.5.2. Mexico Nontuberculous Mycobacterium Treatment Market
8.6. Rest of The World Nontuberculous Mycobacterium Treatment Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Insmed Incorporated
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. RedHill Biopharma,
9.2.3. Novoteris,
9.2.4. Savara,
9.2.5. Beyond Air
9.2.6. Kadmon.
9.2.7. Atara Bio.
9.2.8. Tercica.
9.2.9. JCR Pharmaceuticals.
9.2.10. BioMarin.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption